Oncogene - Table of Contents alert Volume 34 Issue 29

If you are unable to see the message below, click here to view.

Advertisement Frontiers in Cancer Science 2015 Converging Novel Cancer Discoveries 2 - 4 November University Cultural Centre, National University of Singapore Hear innovative science and gain innovative insights to a diverse repertoire of cancer research at the FCS 2015 Conference!  TABLE OF CONTENTS Volume 34, Issue 29 (July 2015) In this issue Review Original Articles Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Explore the benefits of submitting your next research article. Review Top How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? H Lincet and P Icard Oncogene 2015 34: 3751-3759; advance online publication, September 29, 2014; 10.1038/onc.2014.320 Abstract | Full Text Original Articles Top Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer N Andruska, X Zheng, X Yang, W G Helferich and D J Shapiro Oncogene 2015 34: 3760-3769; advance online publication, September 29, 2014; 10.1038/onc.2014.292 Abstract | Full Text Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma S N Brun, S L Markant, L A Esparza, G Garcia, D Terry, J-M Huang, M S Pavlyukov, X-N Li, G A Grant, J R Crawford, M L Levy, E M Conway, L H Smith, I Nakano, A Berezov, M I Greene, Q Wang and R J Wechsler-Reya Oncogene 2015 34: 3770-3779; advance online publication, September 22, 2014; 10.1038/onc.2014.304 Abstract | Full Text NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation M P Licciardello, M K Müllner, G Dürnberger, C Kerzendorfer, B Boidol, C Trefzer, S Sdelci, T Berg, T Penz, M Schuster, C Bock, R Kralovics, G Superti-Furga, J Colinge, S M Nijman and S Kubicek Oncogene 2015 34: 3780-3790; advance online publication, September 29, 2014; 10.1038/onc.2014.319 Abstract | Full Text Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation M-Y Li, P-L Lai, Y-T Chou, A-P Chi, Y-Z Mi, K-H Khoo, G-D Chang, C-W Wu, T-C Meng and G-C Chen Oncogene 2015 34: 3791-3803; advance online publication, September 29, 2014; 10.1038/onc.2014.312 Abstract | Full Text Differential roles of STAT3 in the initiation and growth of lung cancer J Zhou, Z Qu, S Yan, F Sun, J A Whitsett, S D Shapiro and G Xiao Oncogene 2015 34: 3804-3814; advance online publication, October 6, 2014; 10.1038/onc.2014.318 Abstract | Full Text TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation Z Mounir, F Lin, V G Lin, J M Korn, Y Yu, R Valdez, O H Aina, G Buchwalter, A B Jaffe, M Korpal, P Zhu, M Brown, R D Cardiff, J L Rocnik, Y Yang and R Pagliarini Oncogene 2015 34: 3815-3825; advance online publication, September 29, 2014; 10.1038/onc.2014.308 Abstract | Full Text The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis N Prevete, F Liotti, C Visciano, G Marone, R M Melillo and A de Paulis Oncogene 2015 34: 3826-3838; advance online publication, September 29, 2014; 10.1038/onc.2014.309 Abstract | Full Text Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress Y Chen, Z Zhang, K Yang, J Du, Y Xu and S Liu Oncogene 2015 34: 3839-3847; advance online publication, October 6, 2014; 10.1038/onc.2014.310 Abstract | Full Text LKB1 reduces ROS-mediated cell damage via activation of p38 H-G Xu, Y-X Zhai, J Chen, Y Lu, J-W Wang, C-S Quan, R-X Zhao, X Xiao, Q He, K D Werle, H-G Kim, R Lopez, R Cui, J Liang, Y-L Li and Z-X Xu Oncogene 2015 34: 3848-3859; advance online publication, September 29, 2014; 10.1038/onc.2014.315 Abstract | Full Text Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response N Erin, A Podnos, G Tanriover, Ö Duymuş, E Cote, I Khatri and R M Gorczynski Oncogene 2015 34: 3860-3870; advance online publication, September 29, 2014; 10.1038/onc.2014.317 Abstract | Full Text Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells A M Redmond, C Byrne, F T Bane, G D Brown, P Tibbitts, K O’Brien, A D K Hill, J S Carroll and L S Young Oncogene 2015 34: 3871-3880; advance online publication, October 6, 2014; 10.1038/onc.2014.323 Abstract | Full Text Corrigenda Top Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation I Garcia, A J Crowther, V Gama, C R Miller, M Deshmukh and T R Gershon Oncogene 2015 34: 3881; 10.1038/onc.2015.204 Full Text FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction D-W Wu, M-C Lee, N-Y Hsu, T-C Wu, J-Y Wu, Y-C Wang, Y-W Cheng, C-Y Chen and H Lee Oncogene 2015 34: 3882-3883; 10.1038/onc.2015.203 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.